MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Intuitive Surgical Inc

Fechado

SetorSaúde

507.46 2.35

Visão Geral

Variação de preço das ações

24h

Atual

Mín

486.43

Máximo

508.27

Indicadores-chave

By Trading Economics

Rendimento

123M

688M

Vendas

374M

2.4B

P/E

Médio do Setor

76.905

63.778

EPS

2.21

Margem de lucro

28.506

Funcionários

15,638

EBITDA

116M

810M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+26.58% upside

Dividendos

By Dow Jones

Próximos Ganhos

22 de abr. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-30B

177B

Abertura anterior

505.11

Fecho anterior

507.46

Sentimento de Notícias

By Acuity

18%

82%

35 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Intuitive Surgical Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de jan. de 2025, 21:41 UTC

Ganhos

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 de jan. de 2025, 18:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Intuitive to Establish Direct Presence in Europe With Acquisition

18 de out. de 2024, 15:22 UTC

Ganhos
Grandes Movimentos do Mercado

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17 de out. de 2024, 21:33 UTC

Ganhos
Grandes Movimentos do Mercado

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17 de out. de 2024, 20:56 UTC

Ganhos

Intuitive Surgical Posts 3Q Revenue Growth

24 de jan. de 2025, 21:17 UTC

Ganhos

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 de jan. de 2025, 18:18 UTC

Ganhos

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 de jan. de 2025, 13:11 UTC

Principais Notícias

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 de jan. de 2025, 09:51 UTC

Ações em Alta

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 de jan. de 2025, 21:10 UTC

Ganhos

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 de jan. de 2025, 21:09 UTC

Ganhos

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 de jan. de 2025, 21:09 UTC

Ganhos

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 de jan. de 2025, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 de jan. de 2025, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 de jan. de 2025, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 de jan. de 2025, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Net $685.7M >ISRG

23 de jan. de 2025, 21:05 UTC

Ganhos

Intuitive Surgical 4Q EPS $1.88 >ISRG

15 de jan. de 2025, 17:27 UTC

Ganhos

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6 de jan. de 2025, 12:00 UTC

Principais Notícias

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18 de out. de 2024, 15:59 UTC

Ganhos

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18 de out. de 2024, 15:38 UTC

Ganhos

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18 de out. de 2024, 13:28 UTC

Ganhos

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17 de out. de 2024, 21:18 UTC

Ganhos
Grandes Movimentos do Mercado

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

17 de out. de 2024, 20:22 UTC

Ganhos

Intuitive Surgical Adds To 41% Run With Massive Profit Beat, Strong Procedure Growth -- IBD

17 de out. de 2024, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Adj EPS $1.84 >ISRG

17 de out. de 2024, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Rev $2.04B >ISRG

17 de out. de 2024, 20:05 UTC

Ganhos

Intuitive Surgical 3Q EPS $1.56 >ISRG

17 de out. de 2024, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Net $565.1M >ISRG

19 de jul. de 2024, 13:50 UTC

Notícias Principais

Dow Jones, Other Indexes Open Lower As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

19 de jul. de 2024, 13:10 UTC

Notícias Principais

Dow Jones Futures Lower, S&P Higher As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

Comparação entre Pares

Variação de preço

Intuitive Surgical Inc Previsão

Preço-alvo

By TipRanks

26.58% parte superior

Previsão para 12 meses

Média 641.83 USD  26.58%

Máximo 711 USD

Mínimo 570 USD

Com base em 22 analistas de Wall Street que oferecem metas de preço de 12 meses para Intuitive Surgical Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

22 ratings

16

Comprar

6

Manter

0

Vender

Pontuação Técnica

By Trading Central

492.06 / 508.58Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Weak Bullish Evidence

Sentimento

By Acuity

35 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.